Detalles de la búsqueda
1.
The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes.
Diabetologia
; 66(3): 508-519, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459177
2.
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE.
Cardiovasc Diabetol
; 22(1): 100, 2023 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120538
3.
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial.
Cardiovasc Diabetol
; 22(1): 208, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568149
4.
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
Diabetes Obes Metab
; 25(6): 1646-1657, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36782093
5.
Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program.
Cardiovasc Diabetol
; 21(1): 127, 2022 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35787704
6.
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study.
Cardiovasc Diabetol
; 21(1): 195, 2022 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151569
7.
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review.
Rev Endocr Metab Disord
; 23(1): 43-50, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031911
8.
Fixed-ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß-cell function in people with type 2 diabetes.
Diabetes Obes Metab
; 24(6): 1159-1165, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257461
9.
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4.
Nutr Metab Cardiovasc Dis
; 32(11): 2647-2654, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36163215
10.
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence.
Cardiovasc Diabetol
; 20(1): 196, 2021 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583699
11.
Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes.
Nephrol Dial Transplant
; 36(10): 1859-1866, 2021 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32995893
12.
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.
Diabetes Obes Metab
; 23(12): 2632-2642, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34338408
13.
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study.
Diabetes Obes Metab
; 23(7): 1505-1517, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625777
14.
SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes.
Clin Sci (Lond)
; 134(23): 3107-3118, 2020 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33205810
15.
Fixed-dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
Diabetes Obes Metab
; 22(6): 1001-1005, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020696
16.
Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.
Diabetes Obes Metab
; 22(3): 393-403, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31692226
17.
Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study.
Diabetes Obes Metab
; 22(1): 99-106, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31469220
18.
Brain free fatty acid uptake is elevated in morbid obesity, and is irreversible 6 months after bariatric surgery: A positron emission tomography study.
Diabetes Obes Metab
; 22(7): 1074-1082, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32052537
19.
Association of artificially sweetened and sugar-sweetened soft drinks with ß-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study.
Eur J Nutr
; 59(4): 1717-1727, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31486878
20.
Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.
Diabetologia
; 62(1): 178-186, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315341